Cholesterol Testing Products & Services Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Global Cholesterol Management Devices Market Size and is segmented by Products and Services (Products (Devices, Test Kits, and Other Products), and Services), End User (Diagnostic Centers, Hospitals, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers value in USD million for the above segments.

Cholesterol Testing Products & Services Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Cholesterol Testing Products and Services Market Size

Cholesterol Testing Products and Services Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 7.80 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Cholesterol Testing Products and Services Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global Cholesterol Testing Products and Services Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Cholesterol Testing Products and Services Market Analysis

The Global Cholesterol Testing Products and Services Market is expected to register a CAGR of 7.8% during the forecast period.

Due to the COVID-19 pandemic, there has been a decrease in cholesterol testing, which saw demand decline even more rapidly to keep pace with the suspected cases of COVID-19. According to the study titled "Trends in cholesterol testing during the COVID-19 pandemic: COVID-19 and cholesterol testing," published in the American Journal of Preventive Cardiology in June 2021, between March and September 2020, cholesterol testing rates in an extensive integrated healthcare system were 39 percent lower than the same period in 2019. As COVID-19 resurfaces across the United States, mechanisms for safely facilitating cholesterol testing and management for high-risk patients have critical scenarios during COVID-19. Thus, during COVID-19, the cholesterol testing and services market was significantly impacted.

The cholesterol testing products and services market is primarily driven by the growing burden of high cholesterol and cardiac diseases worldwide. The average cholesterol levels are 200 mg/dl. The range higher than this is referred to as hypercholesteremia. The rise in cholesterol levels increases the risk of stroke and heart disease. For instance, according to the research study published in November 2020, titled 'Lipid Profile in Indian Patients with Type 2 Diabetes: The Scope for Atherosclerotic Cardiovascular Disease Risk Reduction', 40.0% of people had hyperlipidemia, of which 14.6% had just received a diagnosis. Elevated LDL cholesterol was the most prevalent lipid abnormality and low-density lipoprotein (LDL) cholesterol levels were shown to be correlated with increased A1C and fasting blood glucose values. Similarly, according to the July 2022 update of the Centers for Disease Control and Prevention, the total cholesterol level in about 94 million American individuals aged 20 or older is higher than 200 mg/dL and in the United States, adults with total cholesterol levels greater than 240 mg/dL number 28 million. Thus, an increase in cardiac diseases especially in cholesterol levels is expected to drive the demand for cholesterol testing and services, boosting the market growth.

Furthermore, various critical development in the market supports the growth of the market. For instance, in January 2021, Researchers in China developed a noninvasive skin cholesterol detection system that could be useful in the long-term lipid management of cardiovascular diseases, meeting a critical unmet need. The traditional indicator, low-density lipoprotein cholesterol (LDL-C), is prone to false positives, and lipid levels measured by routine blood cholesterol tests fluctuate based on diet, exercise, and weight. Thus, development help to bolster the market growth over the forecast period. However, stringent regulatory policies are anticipated to impede market growth over the forecast period.

Cholesterol Testing Products and Services Industry Overview

The global cholesterol testing product and services market is moderately fragmented and competitive. Market players focus on new product launches, innovations, and geographical expansion to strengthen their market share. The key market players operating in the market include Quest Diagnostics, SpectraCell Laboratories Inc., Randox Laboratories Ltd, Thermo Fisher Scientific, and Cell Biolabs Inc., among others.

Cholesterol Testing Products and Services Market Leaders

  1. Quest Diagnostics

  2. SpectraCell Laboratories, Inc.

  3. Randox Laboratories Ltd

  4. Thermo Fisher Scientific

  5. Cell Biolabs, Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Cholesterol Testing Products and Services Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Cholesterol Testing Products and Services Market News

  • In May 2022, Goodbody Health launched its core UK Health 'MOT' test. This new test includes innovative in-clinic diabetes and cholesterol tests, finalizing results in minutes. These tests determine a person's risk for developing cardiac health problems or diabetes over the next ten years.
  • In March 2022, Rosalind Franklin University's (RFU) Community Care Connection and a new partnership with NorthShore University Health System continued to provide life-saving medical care to underserved persons in many North Chicago communities. The Care Coach, a mobile health unit staffed by licensed healthcare professionals, will benefit directly from $680,000 in financing granted by NorthShore's Community Investment Fund (CIF). The mobile unit provides blood pressure control, diabetes screening, BMI, cholesterol testing, and other complimentary health treatments.

Cholesterol Testing Products and Services Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of High Cholesterol and Cardiovascular Diseases
    • 4.2.2 Increasing Awareness Regarding Regulation of Cholesterol Testing
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Policies
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Products and Services
    • 5.1.1 Products
    • 5.1.1.1 Devices
    • 5.1.1.2 Test Kits
    • 5.1.1.3 Other Products and Services
    • 5.1.2 Services
  • 5.2 By End User
    • 5.2.1 Diagnostic Centers
    • 5.2.2 Hospitals
    • 5.2.3 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Quest Diagnostics
    • 6.1.2 SpectraCell Laboratories Inc.
    • 6.1.3 Randox Laboratories Ltd
    • 6.1.4 Thermo Fisher Scientific
    • 6.1.5 Cell Biolabs Inc.
    • 6.1.6 Abbott Laboratories
    • 6.1.7 Clinical Reference Laboratory Inc.
    • 6.1.8 Spectra Laboratories Inc.
    • 6.1.9 Bio-Reference Laboratories
    • 6.1.10 Unilabs
    • 6.1.11 SYNLAB International GmbH
    • 6.1.12 Adicon Clinical Laboratory
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Cholesterol Testing Products and Services Industry Segmentation

A cholesterol test is a blood test to measure each type of cholesterol and particular fats in the blood. As per the scope of the report, cholesterol testing products and services cover the test kits and other cholesterol testing products and testing services offered by the various market players. The cholesterol testing products and services market is segmented by products and services (products (devices, test kits, and other products ), and services), end users (diagnostic centers, hospitals, and other end users), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers value in USD million for the above segments.

By Products and Services Products Devices
Test Kits
Other Products and Services
Services
By End User Diagnostic Centers
Hospitals
Other End Users
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Cholesterol Testing Products and Services Market Research FAQs

What is the current Global Cholesterol Testing Products and Services Market size?

The Global Cholesterol Testing Products and Services Market is projected to register a CAGR of 7.8% during the forecast period (2025-2030)

Who are the key players in Global Cholesterol Testing Products and Services Market?

Quest Diagnostics, SpectraCell Laboratories, Inc., Randox Laboratories Ltd, Thermo Fisher Scientific and Cell Biolabs, Inc. are the major companies operating in the Global Cholesterol Testing Products and Services Market.

Which is the fastest growing region in Global Cholesterol Testing Products and Services Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Cholesterol Testing Products and Services Market?

In 2025, the North America accounts for the largest market share in Global Cholesterol Testing Products and Services Market.

What years does this Global Cholesterol Testing Products and Services Market cover?

The report covers the Global Cholesterol Testing Products and Services Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Cholesterol Testing Products and Services Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Cholesterol Management Devices Industry Report

Statistics for the 2025 Global Cholesterol Testing Products and Services market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Cholesterol Testing Products and Services analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.